Overexpression or hyperactivation of EGFR is strongly associated with poor prognosis in a wide range of cancers, including lung cancer which is a leading cause of cancer mortality worldwide with limited therapeutic options (38). This evidence concerns the gene EGFR and lung carcinoma.